Nikolai is a Professor of Medicine in the College of Medicine and Public Health at Flinders University and the founder of Vaxine Pvt. Ltd, an Adelaide-based biotechnology company. His research interests including vaccines, adjuvants, and immuno-informatics. He has been principal investigator on multiple large grants from the U.S. National Institutes of Health and has won prestigious awards including the 2010 Ernst & Young Entrepreneur of the Year Award and the 2013 Asian Executive of the Year Award. Last year, he took the first human drug developed by artificial intelligence into human influenza vaccine trials. His current focus is on the development of a vaccine against COVID-19 infection.
Dr. Li Yanfeng is the head of IVD business development in GenScript. he is well trained in Cellular biology & Immunology, with extensive research experience in signaling pathways determining B cell biology and T cell functionality. She authored in more than 10 world-renowned journals and led >50 successful clinical trials connecting insights from consumer behavior, skin biology, and intervention efficacy.